1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsGLIA-CTN Community Award is sponsored by Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN). Provides in-kind infrastructure support for novel projects in leukodystrophy research.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Home | Global Leukodystrophy Initiative Clinical Trials Network An NIH-Funded Rare Diseases Clinical Research Network Consortium A consortium of scientists, industry stakeholders, and patient advocacy leaders working together to promote advances in the diagnosis and treatment of leukodystrophies.
Join one of our research studies Participants make it possible for researchers to find new treatments, speed diagnosis, and improve the lives of those affected by rare diseases. Learn About Diseases We Study Rare Research Report: June 2026 Each month, we share summaries of recent Rare Diseases Clinical Research Network grant-funded publications. Catch up on RDCRN research for June 2026.
Rare Research Report: May 2026 Each month, we share summaries of recent Rare Diseases Clinical Research Network grant-funded publications. Catch up on RDCRN research for May 2026. Rare Research Report: March 2026 Each month, we share summaries of recent Rare Diseases Clinical Research Network grant-funded publications.
Catch up on RDCRN research for March 2026.
According to the current listing, eligibility includes: Universities, Academic Health Centers. Confirm the full requirements in the official notice before applying.
GLIA-CTN Community Award is funded by Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Seven research teams will run the first clinical trials aimed at extending human healthspan under ARPA-H PROSPR contracts worth up to $144M. The milestone-based contract model breaks every convention of federal biomedical funding.
Read articleARPA-H PROSPR program funds seven research teams up to $144M to develop the first clinical trials targeting biological aging itself, testing rapamycin analogs, semaglutide, and retrotransposon inhibitors.
Read articleARPA-H awarded $144M across 7 research teams to run the first clinical trials treating aging as a condition — not a disease. How PROSPR reshapes longevity funding and what grant seekers in biotech, academia, and health tech should know.
Read article